PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1
Abstract
Authors
B. Sherif B. Besse B. Solomon L. Bazhenova D.W. Kim J.J. Lin J. Wolf S. Popat K. Goto A.J. de Langen C. Springfeld M. Reynolds D. Odom Y. Yuan A. Lee S.I. Blum S. Thamake F. Ades A. Drilon